U.S. Obesity Rates Show Signs of Decline Amid Ongoing Health Crisis
A recent survey shows that the use of injectable weight loss drugs like Wegovy and Zepbound has increased significantly in the U.S., leading to a decline in the national obesity rate from 39.9% to 37% over three years, with the most notable improvements among those aged 40-64. However, access to these medications remains limited due to high costs and insurance coverage issues.